越南製造加工出口(00422.HK):私有化計劃未獲大多數股東批准 私有化計劃已失效
格隆匯9月14日丨越南製造加工出口(00422.HK)發佈公告,於2020年9月14日,於法院會議上,有關批准私有化計劃的決議案未獲得親身或透過委任代表出席法院會議的大多數獨立股東(佔股份價值不少於75%)通過,及未獲得親自或透過委任代表投票的獨立股東所持股份所附票數75%或以上的批准。
由於該計劃未獲得親身或透過委任代表出席法院會議的大多數獨立股東(佔股份價值不少於75%)通過,及未獲得親自或透過委任代表投票的獨立股東所持股份所附票數75%或以上的批准,該計劃將不會進行及因此已失效;要約期已結束;及股份將維持於聯交所上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.